Picture of Zhaoke Ophthalmology logo

6622 — Zhaoke Ophthalmology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Zhaoke Ophthalmology Says Cyclosporine A Ophthalmic Gel Passed On-Site Regulatory And Clinical Trial Inspections By NMPA

Jan 31 (Reuters) - Zhaoke Ophthalmology Ltd  6622.HK :
    * CYCLOSPORINE A OPHTHALMIC GEL PASSED ON-SITE REGULATORY
AND
CLINICAL TRIAL INSPECTIONS BY NMPA

Further company coverage:  6622.HK 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zhaoke Ophthalmology

See all news